Department of Imaging Physics, MD Anderson Cancer Center, Houston, Texas 77030, United States Department of Bioengineering, Rice University, Houston, Texas 77005, United States ...
The US Food and Drug Administration (FDA) issued draft guidance outlining specific product types for which the FDA believes six-month non-human primate toxicity testing can be eliminated or reduced.
The FDA has released a plan to stop or reduce the use of primates for testing the safety of certain monoclonal antibodies (mAbs), the latest expansion of the regulator’s efforts to eliminate animal ...
On December 2, 2025, the FDA issued draft guidance identifying specific types of monoclonal antibody products for which the agency believes 6-month toxicity testing in nonhuman primates (NHPs) can be ...
Drugmakers may no longer have to test certain experimental antibody drugs on monkeys and other primates to assess their safety, according to draft guidelines the Food and Drug Administration published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results